Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU’s radiopharmaceutical sector, according to the European Medicines Agency (EMA).
Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU’s radiopharmaceutical sector, according to the European Medicines Agency (EMA).